Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Resistant hypertension.

Literature DB >> 23169802

Resistant hypertension.

Aung Myat¹, Simon R Redwood, Ayesha C Qureshi, John A Spertus, Bryan Williams.

Abstract

Entities: Disease

Mesh：

Year: 2012 PMID： 23169802 DOI： 10.1136/bmj.e7473

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

Keyword Cloud
Cited

× No keyword cloud information.

36 in total

1. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Authors: Sarah A Lamb; Yazid N Al Hamarneh; Sherilyn K D Houle; Alexander A Leung; Ross T Tsuyuki
Journal: Can Pharm J (Ott) Date: 2017-11-29

2. Capsule commentary on Fontil, et al. physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.

Authors: Idris Guessous
Journal: J Gen Intern Med Date: 2014-03 Impact factor: 5.128

Review 3. Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

Authors: U Muscha Steckelings; Annette de Kloet; Colin Sumners
Journal: Trends Endocrinol Metab Date: 2017-07-18 Impact factor: 12.015

Review 4. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.

Authors: Satoshi Morimoto; Atsuhiro Ichihara
Journal: Hypertens Res Date: 2020-05-18 Impact factor: 3.872

Review 5. Approaches for the Management of Resistant Hypertension in 2020.

Authors: Wilbert S Aronow
Journal: Curr Hypertens Rep Date: 2020-01-08 Impact factor: 5.369

6. Erucin exhibits vasorelaxing effects and antihypertensive activity by H₂ S-releasing properties.

Authors: Alma Martelli; Eugenia Piragine; Valentina Citi; Lara Testai; Eleonora Pagnotta; Luisa Ugolini; Luca Lazzeri; Lorenzo Di Cesare Mannelli; Onorina Laura Manzo; Mariarosaria Bucci; Carla Ghelardini; Maria Cristina Breschi; Vincenzo Calderone
Journal: Br J Pharmacol Date: 2019-04-15 Impact factor: 8.739

Resistant hypertension.

1. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

2. Capsule commentary on Fontil, et al. physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.

Review 3. Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

Review 4. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.

Review 5. Approaches for the Management of Resistant Hypertension in 2020.

6. Erucin exhibits vasorelaxing effects and antihypertensive activity by H₂ S-releasing properties.

Review 7. Renal denervation for resistant hypertension.

8. Blood Pressure Goals and Targets in the Elderly.

Review 9. Treatment resistant hypertension--investigation and conservative management.

Review 10. Genetics of Resistant Hypertension: the Missing Heritability and Opportunities.

Resistant hypertension.

1. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

2. Capsule commentary on Fontil, et al. physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.

Review 3. Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

Review 4. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.

Review 5. Approaches for the Management of Resistant Hypertension in 2020.

6. Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties.

Review 7. Renal denervation for resistant hypertension.

8. Blood Pressure Goals and Targets in the Elderly.

Review 9. Treatment resistant hypertension--investigation and conservative management.

Review 10. Genetics of Resistant Hypertension: the Missing Heritability and Opportunities.

6. Erucin exhibits vasorelaxing effects and antihypertensive activity by H₂ S-releasing properties.